H M Forsmo1, F Pfeffer1,2, A Rasdal1, G Østgaard3, A C Mohn4, H Körner2,5, C Erichsen1. 1. Department of Gastrointestinal and Emergency Surgery, Haukeland University Hospital, Bergen, Norway. 2. Department of Clinical Medicine, University of Bergen, Bergen, Norway. 3. Department of Anesthesiology, Haukeland University Hospital, Bergen, Norway. 4. Department of Gastrointestinal Surgery, Haugesund Hospital, Haugesund, Norway. 5. Department of Gastrointestinal Surgery, Stavanger University Hospital, Stavanger, Norway.
Abstract
AIM: The aim of this randomized clinical trial was to compare patients treated using a multimodal approach [enhanced recovery after surgery (ERAS)], with a special focus on counselling, to patients treated in a standard conventional care pathway, who underwent elective colorectal resection. METHOD: In a single-centre trial, adult patients eligible for open or laparoscopic colorectal resection were randomized to an ERAS programme or standard care. The primary end-point was postoperative total hospital stay. Identical discharge criteria were defined for both treatment groups. Secondary end-points included postoperative complications, postoperative C-reactive protein levels, postoperative hospital stay, readmission rate and mortality. All parameters were recorded before operation, on the day of surgery and daily thereafter until discharge. RESULTS:Total hospital stay was significantly shorter among patients randomized to ERAS than among the standard group [median 5 days (range 2-50 days) vs median 8 days (range 2-48 days); P = 0.001]. The two treatment groups exhibited similar outcomes regarding overall major and minor morbidity, reoperation rate, readmission rate and 30-day mortality. There were also no differences in tolerance of enteral nutrition or in the inflammatory response, as reflected by postoperative C-reactive protein levels. CONCLUSION:ERAS care was associated with a significantly shorter length of hospital stay. Without any difference in surgical or general complications, tolerance of enteral nutrition or postoperative C-reactive protein levels, peri-operative information and guidance for ensuring that patients comply with the ERAS approach appear to be important factors to reduce the length of hospital stay. Colorectal Disease
RCT Entities:
AIM: The aim of this randomized clinical trial was to compare patients treated using a multimodal approach [enhanced recovery after surgery (ERAS)], with a special focus on counselling, to patients treated in a standard conventional care pathway, who underwent elective colorectal resection. METHOD: In a single-centre trial, adult patients eligible for open or laparoscopic colorectal resection were randomized to an ERAS programme or standard care. The primary end-point was postoperative total hospital stay. Identical discharge criteria were defined for both treatment groups. Secondary end-points included postoperative complications, postoperative C-reactive protein levels, postoperative hospital stay, readmission rate and mortality. All parameters were recorded before operation, on the day of surgery and daily thereafter until discharge. RESULTS: Total hospital stay was significantly shorter among patients randomized to ERAS than among the standard group [median 5 days (range 2-50 days) vs median 8 days (range 2-48 days); P = 0.001]. The two treatment groups exhibited similar outcomes regarding overall major and minor morbidity, reoperation rate, readmission rate and 30-day mortality. There were also no differences in tolerance of enteral nutrition or in the inflammatory response, as reflected by postoperative C-reactive protein levels. CONCLUSION: ERAS care was associated with a significantly shorter length of hospital stay. Without any difference in surgical or general complications, tolerance of enteral nutrition or postoperative C-reactive protein levels, peri-operative information and guidance for ensuring that patients comply with the ERAS approach appear to be important factors to reduce the length of hospital stay. Colorectal Disease
Authors: Amir Elhassan; Ihab Elhassan; Amjad Elhassan; Krish D Sekar; Ryan E Rubin; Richard D Urman; Elyse M Cornett; Alan David Kaye Journal: Curr Pain Headache Rep Date: 2019-03-11
Authors: Joseph C Carmichael; Deborah S Keller; Gabriele Baldini; Liliana Bordeianou; Eric Weiss; Lawrence Lee; Marylise Boutros; James McClane; Scott R Steele; Liane S Feldman Journal: Surg Endosc Date: 2017-08-03 Impact factor: 4.584
Authors: Jason W Denbo; Morgan Bruno; Whitney Dewhurst; Michael P Kim; Ching-Wei Tzeng; Thomas A Aloia; Jose Soliz; Barbara Bryce Speer; Jeffrey E Lee; Matthew H G Katz Journal: Surgery Date: 2018-05-25 Impact factor: 3.982
Authors: Mayou Martin T Tampo; Mark Augustine S Onglao; Marc Paul J Lopez; Marie Dione P Sacdalan; Ma Concepcion L Cruz; Rosielyn T Apellido; Hermogenes J Monroy Iii Journal: Ann Coloproctol Date: 2020-09-18
Authors: Trent W Stethen; Yasir A Ghazi; Robert Eric Heidel; Brian J Daley; Linda Barnes; Donna Patterson; James M McLoughlin Journal: J Gastrointest Oncol Date: 2018-10
Authors: James Wei Tatt Toh; Geoffrey Peter Collins; Nimalan Pathma-Nathan; Toufic El-Khoury; Alexander Engel; Stephen Smith; Arthur Richardson; Grahame Ctercteko Journal: Langenbecks Arch Surg Date: 2022-03-11 Impact factor: 2.895